Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer

Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer

10/15/2012 10:17:24 AM

WILMINGTON, N.C.--Osmotica Pharmaceutical Corp. today announced the appointment of Dr. Praveen Tyle as Executive Vice President and Chief Scientific Officer. He also serves as the Managing Director of Osmotica's Marietta, Georgia site. Forrest Waldon, CEO of Osmotica Pharmaceutical stated, "We are pleased to announce that Praveen Tyle has joined Osmotica as Chief Science Officer and Executive Vice President. Praveen is a proven industry veteran with an impressive record of moving pharmaceutical pipelines to commercial success."

Suggested Articles

Acceleron’s sotatercept outdid placebo at reducing pulmonary vascular resistance in patients with pulmonary arterial hypertension.

China’s Biotheus picked up the rights to Tilt Biotherapeutics’ lead oncolytic virus program in greater China.

A Cedars-Sinai team used stem cells to uncover a key mechanism of young onset Parkinson's, as well as a potential remedy—an existing skin treatment.